Literature DB >> 17763465

Failure to lactate: a possible late effect of cranial radiation.

Karen Johnston1, Marcus Vowels, Susan Carroll, Kristen Neville, Richard Cohn.   

Abstract

We conducted a retrospective review of the lactation experience of female survivors who received 24 Gy cranial radiotherapy as CNS prophylaxis for acute lymphoblastic leukemia in childhood prior to 1982 and who attend the Long-Term Follow-Up Clinic at Sydney Children's Hospital, Randwick, Australia. Median time since diagnosis is 28 years (range 25-37 years). Twelve have produced offspring. Ten report minimal or no breast changes during pregnancy and failure to lactate postpartum. All patients remain in remission. These data suggest a high risk of failure of lactation in women treated during childhood with 24 Gy cranial irradiation. Awareness of this possibility can assist in counseling. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17763465     DOI: 10.1002/pbc.21291

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

Review 1.  Fertility and pregnancy in cancer survivors.

Authors:  Monica Tang; Kate Webber
Journal:  Obstet Med       Date:  2018-03-29

Review 2.  Best Practices in Counseling Young Female Cancer Survivors on Reproductive Health.

Authors:  Ksenya Shliakhtsitsava; Deepika Suresh; Tracy Hadnott; H Irene Su
Journal:  Semin Reprod Med       Date:  2017-10-16       Impact factor: 1.303

Review 3.  Protective effects of breastfeeding for mothers surviving childhood cancer.

Authors:  Susan W Ogg; Melissa M Hudson; Mary E Randolph; James L Klosky
Journal:  J Cancer Surviv       Date:  2011-01-21       Impact factor: 4.442

4.  Breastfeeding practices among childhood cancer survivors.

Authors:  Susan Ogg; James L Klosky; Wassim Chemaitilly; Deo Kumar Srivastava; Mingjuan Wang; Ginger Carney; Rohit Ojha; Leslie L Robison; Cheryl L Cox; Melissa M Hudson
Journal:  J Cancer Surviv       Date:  2020-04-14       Impact factor: 4.442

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.